200 related articles for article (PubMed ID: 31804490)
21. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia.
Swaminathan S; Klemm L; Park E; Papaemmanuil E; Ford A; Kweon SM; Trageser D; Hasselfeld B; Henke N; Mooster J; Geng H; Schwarz K; Kogan SC; Casellas R; Schatz DG; Lieber MR; Greaves MF; Müschen M
Nat Immunol; 2015 Jul; 16(7):766-774. PubMed ID: 25985233
[TBL] [Abstract][Full Text] [Related]
23. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
[TBL] [Abstract][Full Text] [Related]
24. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia.
Look AT
Curr Top Microbiol Immunol; 1997; 220():45-53. PubMed ID: 9103674
[No Abstract] [Full Text] [Related]
25. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination.
Xu Z; Pone EJ; Al-Qahtani A; Park SR; Zan H; Casali P
Crit Rev Immunol; 2007; 27(4):367-97. PubMed ID: 18197815
[TBL] [Abstract][Full Text] [Related]
26. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.
Gu Z; Churchman ML; Roberts KG; Moore I; Zhou X; Nakitandwe J; Hagiwara K; Pelletier S; Gingras S; Berns H; Payne-Turner D; Hill A; Iacobucci I; Shi L; Pounds S; Cheng C; Pei D; Qu C; Newman S; Devidas M; Dai Y; Reshmi SC; Gastier-Foster J; Raetz EA; Borowitz MJ; Wood BL; Carroll WL; Zweidler-McKay PA; Rabin KR; Mattano LA; Maloney KW; Rambaldi A; Spinelli O; Radich JP; Minden MD; Rowe JM; Luger S; Litzow MR; Tallman MS; Racevskis J; Zhang Y; Bhatia R; Kohlschmidt J; Mrózek K; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Evans WE; Jeha S; Pui CH; Yang J; Paietta E; Downing JR; Relling MV; Zhang J; Loh ML; Hunger SP; Mullighan CG
Nat Genet; 2019 Feb; 51(2):296-307. PubMed ID: 30643249
[TBL] [Abstract][Full Text] [Related]
27. AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis.
Teater M; Dominguez PM; Redmond D; Chen Z; Ennishi D; Scott DW; Cimmino L; Ghione P; Chaudhuri J; Gascoyne RD; Aifantis I; Inghirami G; Elemento O; Melnick A; Shaknovich R
Nat Commun; 2018 Jan; 9(1):222. PubMed ID: 29335468
[TBL] [Abstract][Full Text] [Related]
28. [Significance of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia without reproducible chromosomal abnormalities].
Liu XM; Zhang L; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Chen XJ; Wang SC; Yang WY; Guo Y; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Apr; 18(4):287-91. PubMed ID: 27097569
[TBL] [Abstract][Full Text] [Related]
29. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
[TBL] [Abstract][Full Text] [Related]
30. Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia.
Xu LS; Sokalski KM; Hotke K; Christie DA; Zarnett O; Piskorz J; Thillainadesan G; Torchia J; DeKoter RP
J Immunol; 2012 Oct; 189(7):3347-54. PubMed ID: 22956576
[TBL] [Abstract][Full Text] [Related]
31. GEMMs addressing Pax5 loss-of-function in childhood pB-ALL.
Auer F; Ingenhag D; Bhatia S; Enczmann J; Cobaleda C; Sanchez-Garcia I; Borkhardt A; Hauer J
Eur J Med Genet; 2016 Mar; 59(3):166-72. PubMed ID: 26626503
[TBL] [Abstract][Full Text] [Related]
32. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.
An Q; Wright SL; Konn ZJ; Matheson E; Minto L; Moorman AV; Parker H; Griffiths M; Ross FM; Davies T; Hall AG; Harrison CJ; Irving JA; Strefford JC
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17050-4. PubMed ID: 18957548
[TBL] [Abstract][Full Text] [Related]
33. AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model.
Komeno Y; Kitaura J; Watanabe-Okochi N; Kato N; Oki T; Nakahara F; Harada Y; Harada H; Shinkura R; Nagaoka H; Hayashi Y; Honjo T; Kitamura T
Leukemia; 2010 May; 24(5):1018-24. PubMed ID: 20357822
[TBL] [Abstract][Full Text] [Related]
34. PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia.
Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lönnerholm G; Nordgren A; Syvänen AC; Nordlund J
Haematologica; 2016 Jan; 101(1):e20-3. PubMed ID: 26494837
[No Abstract] [Full Text] [Related]
35. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
36. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
Feldhahn N; Henke N; Melchior K; Duy C; Soh BN; Klein F; von Levetzow G; Giebel B; Li A; Hofmann WK; Jumaa H; Müschen M
J Exp Med; 2007 May; 204(5):1157-66. PubMed ID: 17485517
[TBL] [Abstract][Full Text] [Related]
37. Expression of PAX5 splice variants: a phenomenon of stress-induced, illegitimate splicing?
Nebral K; Krehan D; Strehl S
Br J Haematol; 2011 Oct; 155(2):277-80. PubMed ID: 21480862
[No Abstract] [Full Text] [Related]
38. High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse.
McClure BJ; Heatley SL; Rehn J; Breen J; Sutton R; Hughes TP; Suppiah R; Revesz T; Osborn M; White D; Yeung DT; White DL
Br J Haematol; 2020 Oct; 191(2):301-304. PubMed ID: 32731299
[No Abstract] [Full Text] [Related]
39. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
[TBL] [Abstract][Full Text] [Related]
40. Activation-induced cytidine deaminase auto-activates and triggers aberrant gene expression.
Isobe T; Song SN; Tiwari P; Ito H; Yamaguchi Y; Yoshizaki K
FEBS Lett; 2013 Aug; 587(16):2487-92. PubMed ID: 23820005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
